All-trans retinoic acid at low concentration directly stimulates normal adult megakaryocytopoiesis in the presence of thrombopoietin or combined cytokines

European Journal of Haematology

Volumn 63, Issue 3, 1999, Pages 149-153

  Visani, Giuseppe ^b   Ottaviani, Emanuela ^c   Zauli, Giorgio ^a   Tosi, Patrizia ^c   Pellacani, Annalisa ^c   Isidori, Alessandro ^c   Pierpaoli, Sabina ^a   Tura, Sante ^c  

^a Dept of Morphology and Embryology   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c NONE

Author keywords

All trans retinoic acid; Autolog ous transplantation; CD34+; Chemotherapy; Cytokines; Megakaryocytopoiesis; Thrombopoietin

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; RETINOIC ACID;

ARTICLE; CELL CULTURE; CELL MATURATION; COLONY FORMING UNIT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEGAKARYOPOIESIS; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0032842063     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1999.tb01762.x     Document Type: Article

References (27)

1. AMOS B, LOTAN R. Retinoid-sensitive cells and cell lines. Meth Enzymol 1991;190:217-224.
2. DE LUCA LM. Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J 1991;5:2924-2929.
3. TABIN CJ. Retinoids, homeoboxes and growth factors: toward molecular models for limb development. Cell 1991;66:199-205.
4. JESSEL TM. Diffusible factors in vertebrate embryonic induction. Cell 1992;68:257-261.
5. MAVILIO F. Regulation of homeo-box containing genes by morphogens. Eur J Biochem 1993;212:273-279.
6. GRATAS C, MENOT ML, DRESCH C, CHOMIENNE C. Retinoic acid supports granuloCytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia 1993;7:1156-1162.
7. LIPPMAN SM, MEYSKANS FL. Results of the use of vitamin A and retinoids in cutaneous malignancies. Pharmacol Ther 1989;40:107-122.
8. HONG WK, LIPPMAN SM, ITRI LM, et al. Prevention of primary tumors with isotretinoin in squamous-cell carcinoma of head and neck. N Engl J Med 1990;323:795-799.
9. BAILEY-WOOD R, MAY R, JACOBS A. The effect of retinoids on CFU-GM from normal subjects and patients with myelodysplastic syndrome. Br J Haematol 1985;59:15-20.
10. CASTAIGNE S, CHOMIENNE C, DANIEL MT, et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990;76:1704-1709.
11. KIZAKI M, IKEDA Y, TANOSAKI R, et al. Effects of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor-a and retinoid X receptor-a RNA by HL60 cells. Blond 1993;82:3592-3599.
12. HUANG ME, YE YC, CHEM SR. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988;72:567-572.
13. CHAMBON P. The retinoid signalling pathway: molecular and genetic analysis. Semin Cell Biol 1994;5:115-125.
14. EVANS RM. The steroid and thyroid hormone receptor super-family. Science 1988;240:889-895.
15. SAKASHITA A, KIZAKI M, PAKKALA S, et al. 9-cis retinoic acid: effects on normal and leukemic hematopoiesis in vitro. Blood 1993;81:1009-1016.
16. MUINDI J, FRANKEL SR, MILLER WH, et al. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood 1992;79:299-309.
17. VISANI G, DELWEL R, TOUW I, BOOT F, LOWENBERG B. Membrane receptors for interleukin 2 on hematopoietic precursors in chronic myeloid leukemia. Blood 1987;69:1182-1190.
18. ZAULI G, VALVASSORI L, CAPITANI S. Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood. Blood 1993;81:385-390.
19. + cells in the presence of various recombinant cytokines under serum-free conditions. Br J Haematol 1994;86:461-467.
20. LABBAYE C, VALTIERI M, TESTA U, PESCHLE C. Retinoic acid downmodulates erythroid differentiation and GATA1 expression in purified adult-progenitor culture. Blood 1994;83:651-656.
21. + BM cells. Ann Hematol 1993;66:61-66.
22. ASSOIAN RK, SPORN MB. Type b transforming growth factor in human platelets: release during platelet degranulation and activation on vascular smooth muscle cells. J Cell Biol 1986;102:1217-1223.
23. GEISSLER D, LU L, BRUNO E, YANG HH, BROXMEYER HE, HOFFMAN R. The influence of T lymphocyte subsets and humoral factors on colony formation by human bone marrow and blood megakaryocyte progenitor cells in vitro. J Immunol 1986;137:2508-2511.
24. ZAULI G, CATANI L. Human megakaryocyte biology and patophysiology. Crit Rev Oncol/Hematol 1995;21:135-137.
25. MIGLIACCIO AR, MIGLIACCIO G. Human embryonic hematopoiesis: control mechanisms underlying progenitor differentiation in vitro. Developmental Biol 1988;125:127-134.
26. CRIPE L, NEUBERG D, TALLMAN M, et al., A pilot study of recombinant human thrombopoietin (rh-TPO) and GM-CSF following induction therapy in patients older than 55 years with acute myeloid leukemia. Blood 1998;92 (Suppl. 1):616a.
27. SCHIFFER CA, MILLER K, LARSON RA, et al. A double blind, placebo controlled trial evaluating pegylated recombinant human megakaryocyte growth and development factor (MGDF) as an adjunct to induction and consolidation therapy in patients with acute myeloid leukemia (AML). Blood 1998;92 (Suppl. 1):313a.